Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and Encephalopathy, Toxic

3,4-dihydroxyphenylacetaldehyde has been researched along with Encephalopathy, Toxic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ito, S; Ojika, M; Sugumaran, M; Tanaka, H; Wakamatsu, K1
Doorn, JA; Enayah, SH; Fuortes, LJ; Ludewig, G; Vanle, BC1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Encephalopathy, Toxic

ArticleYear
Oxidative Transformations of 3,4-Dihydroxyphenylacetaldehyde Generate Potential Reactive Intermediates as Causative Agents for Its Neurotoxicity.
    International journal of molecular sciences, 2021, Oct-29, Volume: 22, Issue:21

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Neurotoxicity Syndromes; Oxidation-Reduction; Parkinson Disease

2021
PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells.
    Toxicology, 2018, 02-01, Volume: 394

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Male; Neurotoxicity Syndromes; PC12 Cells; Polychlorinated Biphenyls; Rats

2018